More than 100,000 boys between the ages of 3 and 11 received the initial dose of the coronavirus vaccine in what was the first day of immunization for that age group, within the framework of the National Vaccination Plan carried out by the Government throughout the Argentine territory in coordination with the provinces, it was officially reported.
“A big smile and a bigger thank you to their families. We move on, write them down: you take care of them, we take care of ourselves,” Health Minister Carla Vizzotti published today on her account on the social network Twitter, through which she celebrated that ” More than 100,000 boys and girls between the ages of 3 and 11 were vaccinated yesterday on the first day “of inoculation for that age group.
Vizzotti highlighted that “more than 106,000 of our children were vaccinated in the first 24 hours”.
As part of the Strategic Plan for immunization against Covid-19, the Government will distribute 2,062,100 doses of Sinopharm vaccine until Friday and there are 9 million doses in stock exclusively destined to guarantee pediatric vaccination.
In a second tweet, the minister published a photo of a vaccination, in which the health personnel were disguised or had some cheerful detail so that the children would not be afraid and said: “We have always known about your love and your work, today they become more visible. Vaccinators and vaccinators, once again, giving everything to make boys and girls feel at home. “
Then, in dialogue with FM Futurock, he stressed that “there was a lot of adherence and enrollment” for children to receive the coronavirus vaccine and valued the “commitment” to “continue working with those who have any questions.”
Vizzotti referred to the boys with risky conditions that come from “many months of isolation and care” and in this sense he stated that “it is key to protect them and protect them with vaccines that individually reduce transmission and favor those who do not they can vaccinate or those who have low defenses and respond less “.
In this context, the official said in a ministry statement that “the level of enrollment is high, as is the commitment of the provinces and scientific societies to continue working for those who still have questions.”
The minister explained that the Sinopharm vaccine that is being applied in this age group has a well-known platform and said that it is “the same as that used for hepatitis A, some influenza vaccines and the Salk inactivated polio vaccine.”
“This same vaccine with the antigen against Covid-19 was applied to millions of people over 18 years of age in different countries and showed a very good safety profile, with a low rate of adverse effects,” he said in this regard.
Vizzotti indicated that “children with risky conditions come from a situation of many months of isolation, and a lot of care”, so “it is key to protect them.”
Thus, he clarified that “in healthy children the possibility of complications is not zero,” so vaccination is essential for individual protection as well as in reducing the transmission of the virus that causes the disease.
In the province
Meanwhile, the Buenos Aires government has already sent more than 600,000 vaccine shifts for boys and girls between the ages of 3 and 17, according to Governor Axel Kicillof in a message posted on his Twitter account.
“Shifts are being sent for boys and girls,” the Buenos Aires president posted and specified that it involves 567,844 shifts for the first dose (with Pfizer and Sinopharm vaccines) and 70,109 shifts for second doses (with Pfizer and Moderna).
From the provincial government it was detailed that 736,925 of the 2,600,000 children between 3 and 11 years old in conditions of being vaccinated, and 1,141,936 of the 1,600,000 young people between 12 and 17 years who can receive immunization .
In that sense, the Minister of Health of the province of Buenos Aires, Nicolás Kreplak, pointed out that yesterday “the vaccination of 3 to 11 years started very well” and said that during that first day a total of 58,000 were immunized with first doses people of that age group, and “to another 55,000 from 12 to 17 years old.”
Kreplak emphasized that “a unambiguous message must be conveyed: we all recommend the Sinopharm vaccine from 3 to 11 years old and the Pfizer vaccine from 12 to 17 years old” and recalled that “all Health ministers agreed with the strategy vaccination “. (Télam)